HHLR Advisors’s BeOne Medicines Ltd ONC Stock Holding History

HHLR Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$307M	Hold	1,034,306	–	–	18.36%	3
2025 Q4	$314M	Hold	1,034,306	–	–	10.12%	3
2025 Q3	$352M	Hold	1,034,306	–	–	8.61%	5
2025 Q2	$250M	Hold	1,034,306	–	–	8.06%	4
2025 Q1	$282M	Sell	1,034,306 -2,770,100	-73%	-$648M	7.95%	4
2024 Q4	$703M	Sell	3,804,406 -1,372,500	-27%	-$280M	24.34%	1
2024 Q3	$1.16B	Hold	5,176,906	–	–	25.52%	1
2024 Q2	$739M	Hold	5,176,906	–	–	18.22%	2
2024 Q1	$810M	Hold	5,176,906	–	–	17.58%	2
2023 Q4	$934M	Hold	5,176,906	–	–	18.82%	2
2023 Q3	$931M	Hold	5,176,906	–	–	20.79%	1
2023 Q2	$923M	Sell	5,176,906 -295,353	-5%	-$68M	19.66%	1
2023 Q1	$1.18B	Hold	5,472,259	–	–	20.91%	1
2022 Q4	$1.2B	Hold	5,472,259	–	–	25.41%	1
2022 Q3	$738M	Hold	5,472,259	–	–	19.4%	1
2022 Q2	$886M	Hold	5,472,259	–	–	18.98%	1
2022 Q1	$1.03B	Hold	5,472,259	–	–	21.55%	1
2021 Q4	$1.48B	Hold	5,472,259	–	–	22.91%	1
2021 Q3	$1.99B	Hold	5,472,259	–	–	25.98%	1
2021 Q2	$1.88B	Hold	5,472,259	–	–	19.33%	1
2021 Q1	$1.9B	Hold	5,472,259	–	–	18.82%	1
2020 Q4	$1.41B	Hold	5,472,259	–	–	11.24%	2
2020 Q3	$1.57B	Hold	5,472,259	–	–	11.87%	2
2020 Q2	$1.03B	Hold	5,472,259	–	–	9.42%	3
2020 Q1	$674M	Hold	5,472,259	–	–	9.08%	3
2019 Q4	$907M	Hold	5,472,259	–	–	11.3%	2
2019 Q3	$670M	Buy	5,472,259 +1,034,306	+23%	+$137M	9.21%	2
2019 Q2	$550M	Hold	4,437,953	–	–	12.3%	1
2019 Q1	$586M	Hold	4,437,953	–	–	16.32%	1
2018 Q4	$622M	Buy	+4,437,953	New	+$589M	25.82%	1

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

HHLR Advisors's ONC Position: Q1 2026 in Review

HHLR Advisors held its BeOne Medicines Ltd (ONC) position steady in Q1 2026 at 1,034,306 shares worth $307M. The position accounts for 18.36% of the portfolio, ranked #3.

HHLR Advisors first reported a position in ONC in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.99B in Q3 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

HHLR Advisors held 1,034,306 shares of BeOne Medicines Ltd worth $307M as of Q1 2026.
HHLR Advisors left its BeOne Medicines Ltd share count unchanged in Q1 2026.
BeOne Medicines Ltd made up 18.36% of HHLR Advisors's portfolio in Q1 2026, its #3 holding.
HHLR Advisors first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 30 quarters since.
HHLR Advisors's BeOne Medicines Ltd position peaked at $1.99B in Q3 2021.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on HHLR Advisors's 13F filing for Q1 2026, filed 15 May 2026.